The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pulmonx Corp shares valued at $13,824 were sold by French Glendon E. III on Dec 01 ’25. At $1.57 per share, French Glendon E. III sold 8,805 shares. The insider’s holdings dropped to 277,324 shares worth approximately $0.52 million following the completion of this transaction.
Also, Rose Geoffrey Beran sold 6,322 shares, netting a total of over 9,926 in proceeds. Following the sale of shares at $1.57 each, the insider now holds 373,466 shares.
Before that, Lehman David Aaron had sold 10,278 shares from its account. In a trade valued at $16,136, the GENERAL COUNSEL traded Pulmonx Corp shares for $1.57 each. Upon closing the transaction, the insider’s holdings decreased to 10,278 shares, worth approximately $0.48 million.
As published in a research note from Piper Sandler on July 31, 2025, Pulmonx Corp [LUNG] has been rated down from an Overweight to a Neutral and the price target has been revised to $2.50. Analysts at D. Boral Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of December 11, 2024, Citigroup has decreased its “Buy” rating to a “Neutral” for LUNG. Earlier on June 04, 2024, Lake Street initiated its rating. Their recommendation was “a Buy” for LUNG stock.
Analyzing LUNG Stock Performance
On last trading session, Pulmonx Corp [NASDAQ: LUNG] rose 8.00% to $1.89. The stock’s lowest price that day was $1.75, but it reached a high of $1.9371 in the same session. During the last five days, there has been a surge of approximately 11.18%. Over the course of the year, Pulmonx Corp shares have dropped approximately -70.70%. Shares of the company reached a 52-week high of $9.3700 on 02/20/25 and a 52-week low of $1.3100 on 11/20/25.
Support And Resistance Levels for Pulmonx Corp (LUNG)
According to the 24-hour chart, there is a support level at 1.7810, which, if violated, would cause prices to drop to 1.6719. In the upper region, resistance lies at 1.9681. The next price resistance is at 2.0461. RSI (Relative Strength Index) is 58.49 on the 14-day chart, showing neutral technical sentiment.
Is Pulmonx Corp subject to short interest?
Stocks of Pulmonx Corp saw a sharp rise in short interest on 2025-11-14 jumping by 0.62 million shares to 2.04 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 1.42 million shares. A jump of 30.36% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.35.
Which companies own the most shares of Pulmonx Corp (LUNG)?
In terms of Pulmonx Corp share price expectations, FactSet research, analysts set an average price target of 3.25 in the next 12 months, up nearly 85.71% from the previous closing price of $1.75. Analysts anticipate Pulmonx Corp stock to reach 4 by 2025, with the lowest price target being 2.5. In spite of this, 4 analysts ranked Pulmonx Corp stock as Buy at the end of 2025. On February 23, 2024, Wells Fargo assigned a price target of “an Equal weight” to the stock and downgraded coverage with a $14.
